Correlation Between Molecular Partners and TC BioPharm
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and TC BioPharm plc, you can compare the effects of market volatilities on Molecular Partners and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and TC BioPharm.
Diversification Opportunities for Molecular Partners and TC BioPharm
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Molecular and TCBPW is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and TC BioPharm plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm plc and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm plc has no effect on the direction of Molecular Partners i.e., Molecular Partners and TC BioPharm go up and down completely randomly.
Pair Corralation between Molecular Partners and TC BioPharm
Given the investment horizon of 90 days Molecular Partners is expected to generate 8.99 times less return on investment than TC BioPharm. But when comparing it to its historical volatility, Molecular Partners AG is 3.67 times less risky than TC BioPharm. It trades about 0.04 of its potential returns per unit of risk. TC BioPharm plc is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 2.90 in TC BioPharm plc on September 2, 2024 and sell it today you would lose (1.03) from holding TC BioPharm plc or give up 35.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. TC BioPharm plc
Performance |
| Timeline |
| Molecular Partners |
| TC BioPharm plc |
Molecular Partners and TC BioPharm Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and TC BioPharm
The main advantage of trading using opposite Molecular Partners and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.| Molecular Partners vs. Tff Pharmaceuticals | Molecular Partners vs. Eliem Therapeutics | Molecular Partners vs. Inhibrx | Molecular Partners vs. Enliven Therapeutics |
| TC BioPharm vs. Protagenic Therapeutics | TC BioPharm vs. bioAffinity Technologies Warrant | TC BioPharm vs. American Rebel Holdings | TC BioPharm vs. Alvotech Warrant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |